Kocitaf 50mg/200mg/25mg Tablet is unsafe to use in patients with liver disease and should be avoided.This revolutionary drug is largely remaining explored for its opportunity role in oncology, particularly focusing on several kinds of cancer. Researchers are investigating its application in autoimmune disorders, aiming to leverage its distinctive s